The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates
Open accessAbstract
An important unknown during the coronavirus disease-2019 (COVID-19) pandemic has been the infection fatality rate (IFR). This differs from the case fatality rate (CFR) as an estimate of the number of deaths and as a proportion of the total number of cases, including those who are mild and asymptomatic. While the CFR is extremely valuable for experts, IFR is increasingly being called for by policy makers and the lay public as an estimate of the overall mortality from COVID-19. METHODS: Pubmed, Medline, SSRN, and Medrxiv were searched using a set of terms and Boolean operators on 25/04/2020 and re-searched on 14/05/2020, 21/05/2020 and 16/06/2020. Articles were screened for inclusion by both authors. Meta-analysis was performed in Stata 15.1 by using the metan command, based on IFR and confidence intervals extracted from each study. Google/Google Scholar was used to assess the grey literature relating to government reports. RESULTS: After exclusions, there were 24 estimates of IFR included in the final meta-analysis, from a wide range of countries, published between February and June 2020. The meta-analysis demonstrated a point estimate of IFR of 0.68% (0.53%-0.82%) with high heterogeneity (p < 0.001). CONCLUSION: Based on a systematic review and meta-analysis of published evidence on COVID-19 until July 2020, the IFR of the disease across populations is 0.68% (0.53%-0.82%). However, due to very high heterogeneity in the meta-analysis, it is difficult to know if this represents a completely unbiased point estimate. It is likely that, due to age and perhaps underlying comorbidities in the population, different places will experience different IFRs due to the disease. Given issues with mortality recording, it is also likely that this represents an underestimate of the true IFR figure. More research looking at age-stratified IFR is urgently needed to inform policymaking on this front.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An interactive web-based dashboard to track COVID-19 in real time
Dong, E., Du, H., & Gardner, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30120-1 · Cited by 10,048
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Rothan, H. A., & Byrareddy, S. N. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102433 · Cited by 5,840
Presumed Asymptomatic Carrier Transmission of COVID-19
Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D.-Y., Chen, L., & Wang, M. (2020) · JAMA · doi:10.1001/jama.2020.2565 · Cited by 4,498
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., Cuomo-Dannenburg, G., Thompson, H., Walker, P. G. T., Fu, H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30243-7 · Cited by 3,660
Hoy, D., Brooks, P., Woolf, A., Blyth, F., March, L., Bain, C., Baker, P., Smith, E., & Buchbinder, R. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.11.014 · Cited by 2,555 · cited 1×
“Serological surveys were rated using a the risk of bias in prevalence tool with a resulting estimate in line with Cochrane GRADE criteria of low, moderate, or high (13).”
MethodClinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients
Liu, K., Chen, Y., Lin, R., & Han, K. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.005 · Cited by 1,642
Kucirka, L. M., Lauer, S. A., Laeyendecker, O., Boon, D., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-1495 · Cited by 1,414
Spread of SARS-CoV-2 in the Icelandic population
Gudbjartsson, D. F., Helgason, A., Jonsson, H., Magnusson, O. T., Melsted, P., Norddahl, G. L., Saemundsdottir, J., Sigurdsson, A., Sulem, P., Agustsdottir, A. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2006100 · Cited by 1,248
Characteristics of COVID-19 infection in Beijing
Tian, S., Hu, N., Lou, J., Chen, K., Kang, X., Xiang, Z., Chen, H., Wang, D., Liu, N., Liu, D., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.02.018 · Cited by 1,231
Estimating the burden of SARS-CoV-2 in France
Salje, H., Tran Kiem, C., Lefrancq, N., Courtejoie, N., Bosetti, P., Paireau, J., Andronico, A., Hozé, N., Richet, J., Dubost, C.-L., et al. (2020) · Science · doi:10.1126/science.abc3517 · Cited by 1,038
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
Sutton, D., Fuchs, K., D’Alton, M., & Goffman, D. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009316 · Cited by 1,029
Stringhini, S., Wisniak, A., Piumatti, G., Azman, A. S., Lauer, S. A., Baysson, H., De Ridder, D., Petrovic, D., Schrempft, S., Marcus, K., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31304-0 · Cited by 990
Levin, A. T., Hanage, W. P., Owusu-Boaitey, N., Cochran, K. B., Walsh, S. P., & Meyerowitz-Katz, G. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00698-1 · Cited by 844
Self-citationDiagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis
Lisboa Bastos, M., Tavaziva, G., Abidi, S. K., Campbell, J. R., Haraoui, L.-P., Johnston, J. C., Lan, Z., Law, S., MacLean, E., Trajman, A., et al. (2020) · BMJ · doi:10.1136/bmj.m2516 · Cited by 832
Infection fatality rate of COVID-19 inferred from seroprevalence data
Ioannidis, J. P. A. (2021) · Bulletin of the World Health Organization · doi:10.2471/blt.20.265892 · Cited by 684
COVID-19 antibody seroprevalence in santa clara county, california
Bendavid, E., Mulaney, B., Sood, N., Shah, S., Bromley-Dulfano, R., Lai, C., Weissberg, Z., Saavedra-Walker, R., Tedrow, J., Bogan, A., et al. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyab010 · Cited by 669
Bryan, A., Pepper, G., Wener, M. H., Fink, S. L., Morishima, C., Chaudhary, A., Jerome, K. R., Mathias, P. C., & Greninger, A. L. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00941-20 · Cited by 527
False negative of RT‐PCR and prolonged nucleic acid conversion in COVID‐19: Rather than recurrence
Xiao, A. T., Tong, Y. X., & Zhang, S. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25855 · Cited by 522
Russell, T. W., Hellewell, J., Jarvis, C. I., van Zandvoort, K., Abbott, S., Ratnayake, R., CMMID COVID-19 working group, Flasche, S., Eggo, R. M., Edmunds, W. J., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.12.2000256 · Cited by 464
Garcia-Basteiro, A. L., Moncunill, G., Tortajada, M., Vidal, M., Guinovart, C., Jiménez, A., Santano, R., Sanz, S., Méndez, S., Llupià, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17318-x · Cited by 408
Sood, N., Simon, P., Ebner, P., Eichner, D., Reynolds, J., Bendavid, E., & Bhattacharya, J. (2020) · JAMA · doi:10.1001/jama.2020.8279 · Cited by 406
Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany
Streeck, H., Schulte, B., Kümmerer, B. M., Richter, E., Höller, T., Fuhrmann, C., Bartok, E., Dolscheid-Pommerich, R., Berger, M., Wessendorf, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19509-y · Cited by 396
Jung, S.-M., Akhmetzhanov, A. R., Hayashi, K., Linton, N. M., Yang, Y., Yuan, B., Kobayashi, T., Kinoshita, R., & Nishiura, H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020523 · Cited by 374
Nishiura, H., Kobayashi, T., Yang, Y., Hayashi, K., Miyama, T., Kinoshita, R., Linton, N., Jung, S.-M., Yuan, B., Suzuki, A., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020419 · Cited by 286
Fontanet, A., Tondeur, L., Grant, R., Temmam, S., Madec, Y., Bigot, T., Grzelak, L., Cailleau, I., Besombes, C., Ungeheuer, M.-N., et al. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.15.2001695 · Cited by 264
The important role of serology for COVID-19 control
Winter, A. K., & Hegde, S. T. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30322-4 · Cited by 216
Estimating case fatality rates of COVID-19
Spychalski, P., Błażyńska-Spychalska, A., & Kobiela, J. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30246-2 · Cited by 189
The UK’s public health response to covid-19
Scally, G., Jacobson, B., & Abbasi, K. (2020) · BMJ · doi:10.1136/bmj.m1932 · Cited by 189
Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil
Silveira, M. F., Barros, A. J. D., Horta, B. L., Pellanda, L. C., Victora, G. D., Dellagostin, O. A., Struchiner, C. J., Burattini, M. N., Valim, A. R. M., Berlezi, E. M., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0992-3 · Cited by 167
Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland
Perez-Saez, J., Lauer, S. A., Kaiser, L., Regard, S., Delaporte, E., Guessous, I., Stringhini, S., Azman, A. S., Alioucha, D., Arm-Vernez, I., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30584-3 · Cited by 164
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
Shakiba, M., Nazemipour, M., Salari, A., Mehrabian, F., Nazari, S. S. H., Rezvani, S. M., Ghasempour, Z., Heidarzadeh, A., & Mansournia, M. A. (2021) · Emerging Infectious Diseases · doi:10.3201/eid2702.201960 · Cited by 164
Estimating Influenza-Associated Deaths in the United States
Thompson, W., Moore, M. R., Weintraub, E., Cheng, P., Jin, X., Bridges, C. B., Bresee, J., & Shay, D. K. (2009) · American Journal of Public Health · doi:10.2105/ajph.2008.151944 · Cited by 153
COVID-19 Serological Tests: How Well Do They Actually Perform?
Ghaffari, A., Meurant, R., & Ardakani, A. (2020) · Diagnostics · doi:10.3390/diagnostics10070453 · Cited by 148
Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors
Erikstrup, C., Hother, C., Pedersen, O. B., Mølbak, K., Skov, R. L., Holm, D. K., Sækmose, S. G., Nilsson, A. C., Brooks, P. T., Boldsen, J. K., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa849 · Cited by 148
Modig, K., Ahlbom, A., & Ebeling, M. (2020) · European Journal of Public Health · doi:10.1093/eurpub/ckaa218 · Cited by 127
Using Early Data to Estimate the Actual Infection Fatality Ratio from COVID-19 in France
Roques, L., Klein, E. K., Papaix, J. J., Sar, A., & Soubeyrand, S. (2020) · Biology · doi:10.3390/biology9050097 · Cited by 119
Covid-19: UK starts social distancing after new model points to 260 000 potential deaths
Mahase, E. (2020) · British medical journal · doi:10.1136/bmj.m1089 · Cited by 110
Estimating The Infection Fatality Rate Among Symptomatic COVID-19 Cases In The United States
Basu, A. (2020) · Health Affairs · doi:10.1377/hlthaff.2020.00455 · Cited by 110
Herd immunity thresholds for SARS-CoV-2 estimated from unfolding epidemicsPreprint
Aguas, R. J., Gonçalves, G., Ferreira, M. U., & Gomes, M. G. M. (2020) · medRxiv · doi:10.1101/2020.07.23.20160762 · Cited by 106
Infection Fatality Risk of the Pandemic A(H1N1)2009 Virus in Hong Kong
Wong, J. Y., Wu, P., Nishiura, H., Goldstein, E., Lau, E. H. Y., Yang, L., Chuang, S. K., Tsang, T., Peiris, M. J. S., Wu, J. T. K., et al. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws314 · Cited by 101
Thompson, C., Grayson, N. E., Paton, R. S., Bolton, J. S., Lourenço, J., Penman, B. S., Lee, L. N., Odon, V., Mongkolsapaya, J., Chinnakannan, S. K., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.42.2000685 · Cited by 98
Herzog, S. A., Bie, J. D., Abrams, S., Wouters, I., Ekinci, E., Patteet, L., Coppens, A., Spiegeleer, S. D., Beutels, P., Damme, P. V., et al. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.9.2100419 · Cited by 91
SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak
Valenti, L., Bergna, A., Pelusi, S., Facciotti, F., Lai, A., Tarkowski, M., Berzuini, A., Caprioli, F., Santoro, L., Baselli, G., et al. (2020) · doi:10.1101/2020.05.11.20098442 · Cited by 88 · cited 2×
“The most common reason for exclusion was selection bias — many studies only looked at targeted populations in their seroprevalence data, and thus could not be used as population estimators of IFR (Erikstrup et al., 2020; Doi et al., 2020; Takita et al., 2020; Jerkovic et al., 2020; Valenti et al., 2020; Garcia-Basteir…”
Serological tests facilitate identification of asymptomatic SARS‐CoV‐2 infection in Wuhan, China
Wu, X., Fu, B., Chen, L., & Feng, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25904 · Cited by 87
Case fatality rate in COVID-19: a systematic review and meta-analysisPreprint
Kahathuduwa, C. N., Dhanasekara, C. S., & Chin, S.-H. (2020) · medRxiv · doi:10.1101/2020.04.01.20050476 · Cited by 86
Hallal, P. C., Hartwig, F. P., Horta, B. L., Victora, G. D., da Silveira, M. F., Struchiner, C. J., Vidaletti, L. P., Neumann, N. A., Pellanda, L. C., Dellagostin, O. A., et al. (2020) · medRxiv · doi:10.1101/2020.05.30.20117531 · Cited by 86
Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study.Preprint
Snoeck, C. J., Vaillant, M., Abdelrahman, T., Satagopam, V., Turner, J. D., Beaumont, K., Gomes, C. P. C., Fritz, J. V., Schröder, V. E., Kaysen, A., et al. (2020) · medRxiv · doi:10.1101/2020.05.11.20092916 · Cited by 79
Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased?
Takahashi, S., Greenhouse, B., & Rodríguez-Barraquer, I. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa523 · Cited by 79
IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Staines, H. M., Kirwan, D. E., Clark, D. J., Adams, E. R., Augustin, Y. S., Byrne, R. L., Cocozza, M., Cubas-Atienzar, A. I., Cuevas, L. E., Cusinato, M., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2701.203074 · Cited by 78
Doi, A., Iwata, K., Kuroda, H., Hasuike, T., Nasu, S., Kanda, A., Nagao, T., Nishioka, H., Tomii, K., Morimoto, T., et al. (2021) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2021.100747 · Cited by 77
Modi, C., Böhm, V., Ferraro, S., Stein, G., & Seljak, U. (2020) · medRxiv · doi:10.1101/2020.04.15.20067074 · Cited by 72
Cluster of COVID-19 in Northern France: A Retrospective Closed Cohort StudyPreprint
Fontanet, A. L., Tondeur, L., Madec, Y., Grant, R., Besombes, C., Jolly, N., Pellerin, S. F., Ungeheuer, M., Cailleau, I., Kuhmel, L., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3582749 · Cited by 70
Herd immunity is not a realistic exit strategy during a COVID-19 outbreakPreprint
Slot, E., Hogema, B. M., Reusken, C. B. E. M., Reimerink, J. H. J., Molier, M., Karregat, J. H. M., IJlst, J., Novotny, V. M. J., van Lier, R. A. W., & Zaaijer, H. L. (2020) · Research Square · doi:10.21203/rs.3.rs-25862/v1 · Cited by 64
An empirical estimate of the infection fatality rate of COVID-19 from the first Italian outbreakPreprint
Rinaldi, G., & Paradisi, M. (2020) · medRxiv · doi:10.1101/2020.04.18.20070912 · Cited by 47
Estimating the Global Infection Fatality Rate of COVID-19Preprint
Grewelle, R. E., & Leo, G. A. D. (2020) · medRxiv · doi:10.1101/2020.05.11.20098780 · Cited by 40
Jerković, I., Ljubić, T., Bašić, Ž., Kružić, I., Kunac, N., Bežić, J., Vuko, A., Markotić, A., & Anđelinović, Š. (2020) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000002020 · Cited by 29
The value of serology testing to manage SARS-CoV-2 infections
Fernández‐Barat, L., López-Aladid, R., & Torres, A. (2020) · European Respiratory Journal · doi:10.1183/13993003.02411-2020 · Cited by 21
Wilson, L. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3590771 · Cited by 18
Are SARS-CoV-2 seroprevalence estimates biased?Preprint
Takahashi, S., Greenhouse, B., & Rodríguez-Barraquer, I. (2020) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/y3fxt · Cited by 16
Herzog, de Bie, A., Wouters, Ekinci, Patteet, Coppens, Spiegeleer, D., Beutels, Damme, P. V., et al. (2021) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.4664403 · Cited by 11
Cited by
The effect of large-scale anti-contagion policies on the COVID-19 pandemic
Hsiang, S., Allen, D., Annan-Phan, S., Bell, K., Bolliger, I., Chong, T., Druckenmiller, H., Huang, L. Y., Hultgren, A., Krasovich, E., et al. (2020) · Nature · doi:10.1038/s41586-020-2404-8 · Cited by 1,379
Levin, A. T., Hanage, W. P., Owusu-Boaitey, N., Cochran, K. B., Walsh, S. P., & Meyerowitz-Katz, G. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00698-1 · Cited by 844
Self-citationFalse-negative results of initial RT-PCR assays for COVID-19: A systematic review
Arevalo-Rodriguez, I., Buitrago-Garcia, D., Simancas-Racines, D., Zambrano-Achig, P., Del Campo, R., Ciapponi, A., Sued, O., Martinez-García, L., Rutjes, A. W., Low, N., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0242958 · Cited by 656
Infection fatality rate of COVID-19 inferred from seroprevalence data
Ioannidis, J. P. A. (2021) · Bulletin of the World Health Organization · doi:10.2471/blt.20.265892 · Cited by 684
Lim, Z. J., Subramaniam, A., Ponnapa Reddy, M., Blecher, G., Kadam, U., Afroz, A., Billah, B., Ashwin, S., Kubicki, M., Bilotta, F., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202006-2405oc · Cited by 369
Metadata
- Authors
- Meyerowitz-Katz, G., & Merone, L.
- Venue
- International Journal of Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 101
- Pages
- 138-148
- ISSN
- 1201-9712 (ISSN-L)
- OpenAlex
- W3089992861
- Cited by
- 566
- References
- 60
- FWCI
- 4.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.